Skip Navigation

Cardiovascular Research 2004 63(2):347-356; doi:10.1016/j.cardiores.2004.04.004
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Furukawa, Y.
Right arrow Articles by Mitchell, R. N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furukawa, Y.
Right arrow Articles by Mitchell, R. N
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Wild-type but not interferon-{gamma}-deficient T cells induce graft arterial disease in the absence of B cells

Yutaka Furukawaa,1, Sarah E Coleb, Ravi V Shahb, Yoshihiro Fukumotoa,2, Peter Libbya and Richard N Mitchell*,b

aLeducq Center for Cardiovascular Research, Cardiovascular Division, Department of Medicine, USA
bImmunology Research Division, Department of Pathology, Brigham and Women's Hospital, 77 Avenue Louis Pasteur, NRB 730D, Boston, MA 02115, USA

* Corresponding author. Tel.: +1-617-525-4303; fax: +1-617-525-4329. Email address: rmitchell{at}rics.bwh.harvard.edu

Objective: Interferon-{gamma} (IFN-{gamma}), a cytokine produced primarily by T cells and by activated macrophages, plays a central role in the pathogenesis of graft arterial disease (GAD). This study investigated whether T cells can induce GAD in the absence of humoral alloresponses and whether activated macrophages or other host cell types can substitute as sources of IFN-{gamma} in GAD. Methods: Wild-type (WT), IFN-{gamma}–/–, or recombination-activating-gene-1–/– (RAG-1–/–; lacking mature T and B cells) mice received MHC II-disparate hearts. The grafts were harvested 8 weeks post-transplant and histological and immunohistochemical analyses, RNase protection assay (RPA), and flow cytometry were used to evaluate GAD lesions, infiltrating cell populations, and IFN-{gamma} expression by infiltrating cells. Results: Moderate-to-severe GAD developed in WT recipient allografts, associated with abundant IFN-{gamma} expression by both infiltrating T cells and macrophages. No GAD developed in IFN-{gamma}–/– or in RAG-1–/– hosts, nor was any IFN-{gamma} expression evident. RAG-1–/– hosts receiving naïve WT or IFN-{gamma}–/– T cells (107) after heart transplantation demonstrated no mature B cells but showed persistence of transferred T cells up to 8 weeks post-transplant. In the complete absence of B cells and alloantibody, transfer of WT T cells into RAG-1–/– recipients yielded GAD, with associated IFN-{gamma} expression by the transferred T cells and the host macrophages. Transfer of IFN-{gamma}–/– T cells induced neither GAD nor host macrophage IFN-{gamma} expression. Conclusions: T cells, even in the absence of B cells, suffice to induce GAD, and T cell-derived IFN-{gamma} plays a critical role in GAD pathogenesis.

KEYWORDS Transplantation; Leukocytes; Cytokines; Atherosclerosis


1 Current address: Dr. Yutaka Furukawa, Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Kawaharacho, Sakyo-ku, Kyoto 606-8097, Japan.

2 Current address: Dr. Yoshihiro Fukumoto, Department of Cardiovascular Medicine, Kyushu University Graduate School of Medicine, Fukuoka, Japan.

Time for primary review 41 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.